Posted By Coherent Market Insights
Posted on October 8, 2021
The global COVID-19 Rapid Diagnostic Test market is expected to reach US$ 7,660.2 Mn by 2028 from US$ 3,422.1 Mn in 2021, at a CAGR of 12.2%. The base year considered for the study is 2020 and the forecast period 2021-2028.
Coronavirus is a family of enveloped, single stranded RNA viruses that infect humans, chimpanzees, other mammals, and avian species. Coronavirus generally causes gastrointestinal and respiratory infections. The severity of infection caused by Coronavirus can range from common cold to highly severe MERS (Middle East Respiratory Syndrome). SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus) is a novel Coronavirus which has been identified in early 2020 by the World Health Organization. COVID-19 infection caused by SARS-CoV-2, emerged in December 2019 and is highly transmissible and life-threatening. It takes around two to fourteen days for a person to show symptoms after the exposure to the virus. Symptoms may range from common cold like symptoms such as cough, congestion or runny nose, headache, and fever to severe life-threatening conditions such as kidney failure, stroke, heart attack, and others. However, some people suffering from COVID-19 infection may not show symptoms at all and still be contagious to healthy people. Thus, it is essential to test for COVID-19 infection so that the spread of COVID-19 can be controlled.
Request Sample COVID-19 Rapid Diagnostic Test market Report @
https://www.coherentmarketinsights.com/insight/request-sample/4568
Key players operating in the market are focusing on launching of new diagnostics for COVID-19 detection and submitting application for its approval, which is expected to drive growth of the global COVID-19 rapid diagnostic test market over the forecast period.
For instance, in May 2020, Sherlock Biosciences, a Cambridge based biotechnology company received the U.S. Food and Drug Administration (FDA) approval for emergency authorization of its CRISPR-based COVID-19 diagnostic test, thus making it the first ever COVID-19 test using CRISPR technology.
Furthermore, in September 2020, Mammoth Biosciences, a U.S. based biotechnology company received emergency use authorization by the U.S. FDA for its SARS-CoV-2 DETECTR Reagent Kit which is based on CRISPR technology. Moreover, in September 2020, the U.S. FDA granted emergency use status to MiraDx, a U.S. based molecular genetics company for its SARS-CoV-2 RT-PCR assay used for detection of COVID-19.
Newer innovations in the field of COVID-19 diagnostics would propel the global COVID-19 rapid diagnostic test market growth over the forecast period. For instance, in March 2021, Roche Holding AG, a Swiss pharmaceutical company, launched its new rapid antigen nasal kit for quicker diagnosis of COVID-19 infection. This COVID-19 diagnosis kit gives results within 15 minutes of sample collection and ensures minimum contact between the healthcare professional and the suspected COVID-19 positive patient as the sample is collected from nasal secretions rather than nasopharyngeal.
Ask for PDF sample COVID-19 Rapid Diagnostic Test market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4568
The objectives of this study are as follows:
To define, describe, and forecast the global COVID-19 Rapid Diagnostic Test market by product & service, technique, design, application, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for the key players
To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the World
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
To track and analyze competitive developments in the COVID-19 Rapid Diagnostic Test market, such as agreements, collaborations, acquisitions, product launches, expansions, and R&D activities
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Reports available at attractive prices for first-time buyers! Offer expires soon!
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4568
Available Customizations
With the given market data, Coherent Market Insights offers customizations as per the company‘s specific needs.
The following customization options are available for this report.
This report segments the COVID-19 Rapid Diagnostic Test market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2020, the test kits segment accounted for the largest share of the total market. The growing demand for COVID-19 Rapid Diagnostic Test in research as well as diagnostics to understand the genetic variability of chronic disorders is propelling the growth of this COVID-19 Rapid Diagnostic Test market segment.
Based on design, the COVID-19 Rapid Diagnostic Test market is segmented into predesigned and customized panels. The customized COVID-19 Rapid Diagnostic Test segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the evolving needs of the emerging therapeutic and diagnostic application sectors and the increasing number of clinical and preclinical research studies.
The COVID-19 Rapid Diagnostic Test market is fragmented with the presence of several small and big players. Prominent players in this market include Abbott, F. Hoffmann-La Roche AG, Cardinal Health, Alfa Scientific Designs Inc., Danaher, Bio-Rad Laboratories Inc., Artron Laboratories Inc., Trinity Biotech, bioMérieux SA, Creative Diagnostics, ACON Laboratories Inc., Thermo Fisher Scientific, Inc., Sight Diagnostics Ltd., Meridian Bioscience, Quest Diagnostics, Perkin Elmer, Inc., Luminex Corporation, Laboratory Corporation of America Holdings, and Veredus Laboratories
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post COVID-19 Rapid Diagnostic Test Market to See Booming Overall Study 2021-2028 | Abbott, F. Hoffmann-La Roche AG, Cardinal Health, Alfa Scientific Designs appeared first on Gatorledger.
The global COVID-19 Rapid Diagnostic Test market is expected to reach US$ 7,660.2 Mn by 2028 from US$ 3,422.1 Mn in 2021, at a CAGR of 12.2%. The base year considered for the study is 2020 and the forecast period 2021-2028.
Coronavirus is a family of enveloped, single stranded RNA viruses that infect humans, chimpanzees, other mammals, and avian species. Coronavirus generally causes gastrointestinal and respiratory infections. The severity of infection caused by Coronavirus can range from common cold to highly severe MERS (Middle East Respiratory Syndrome). SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus) is a novel Coronavirus which has been identified in early 2020 by the World Health Organization. COVID-19 infection caused by SARS-CoV-2, emerged in December 2019 and is highly transmissible and life-threatening. It takes around two to fourteen days for a person to show symptoms after the exposure to the virus. Symptoms may range from common cold like symptoms such as cough, congestion or runny nose, headache, and fever to severe life-threatening conditions such as kidney failure, stroke, heart attack, and others. However, some people suffering from COVID-19 infection may not show symptoms at all and still be contagious to healthy people. Thus, it is essential to test for COVID-19 infection so that the spread of COVID-19 can be controlled.
Request Sample COVID-19 Rapid Diagnostic Test market Report @
https://www.coherentmarketinsights.com/insight/request-sample/4568
Key players operating in the market are focusing on launching of new diagnostics for COVID-19 detection and submitting application for its approval, which is expected to drive growth of the global COVID-19 rapid diagnostic test market over the forecast period.
For instance, in May 2020, Sherlock Biosciences, a Cambridge based biotechnology company received the U.S. Food and Drug Administration (FDA) approval for emergency authorization of its CRISPR-based COVID-19 diagnostic test, thus making it the first ever COVID-19 test using CRISPR technology.
Furthermore, in September 2020, Mammoth Biosciences, a U.S. based biotechnology company received emergency use authorization by the U.S. FDA for its SARS-CoV-2 DETECTR Reagent Kit which is based on CRISPR technology. Moreover, in September 2020, the U.S. FDA granted emergency use status to MiraDx, a U.S. based molecular genetics company for its SARS-CoV-2 RT-PCR assay used for detection of COVID-19.
Newer innovations in the field of COVID-19 diagnostics would propel the global COVID-19 rapid diagnostic test market growth over the forecast period. For instance, in March 2021, Roche Holding AG, a Swiss pharmaceutical company, launched its new rapid antigen nasal kit for quicker diagnosis of COVID-19 infection. This COVID-19 diagnosis kit gives results within 15 minutes of sample collection and ensures minimum contact between the healthcare professional and the suspected COVID-19 positive patient as the sample is collected from nasal secretions rather than nasopharyngeal.
Ask for PDF sample COVID-19 Rapid Diagnostic Test market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4568
The objectives of this study are as follows:
To define, describe, and forecast the global COVID-19 Rapid Diagnostic Test market by product & service, technique, design, application, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for the key players
To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the World
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
To track and analyze competitive developments in the COVID-19 Rapid Diagnostic Test market, such as agreements, collaborations, acquisitions, product launches, expansions, and R&D activities
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Reports available at attractive prices for first-time buyers! Offer expires soon!
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4568
Available Customizations
With the given market data, Coherent Market Insights offers customizations as per the company‘s specific needs.
The following customization options are available for this report.
This report segments the COVID-19 Rapid Diagnostic Test market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2020, the test kits segment accounted for the largest share of the total market. The growing demand for COVID-19 Rapid Diagnostic Test in research as well as diagnostics to understand the genetic variability of chronic disorders is propelling the growth of this COVID-19 Rapid Diagnostic Test market segment.
Based on design, the COVID-19 Rapid Diagnostic Test market is segmented into predesigned and customized panels. The customized COVID-19 Rapid Diagnostic Test segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the evolving needs of the emerging therapeutic and diagnostic application sectors and the increasing number of clinical and preclinical research studies.
The COVID-19 Rapid Diagnostic Test market is fragmented with the presence of several small and big players. Prominent players in this market include Abbott, F. Hoffmann-La Roche AG, Cardinal Health, Alfa Scientific Designs Inc., Danaher, Bio-Rad Laboratories Inc., Artron Laboratories Inc., Trinity Biotech, bioMérieux SA, Creative Diagnostics, ACON Laboratories Inc., Thermo Fisher Scientific, Inc., Sight Diagnostics Ltd., Meridian Bioscience, Quest Diagnostics, Perkin Elmer, Inc., Luminex Corporation, Laboratory Corporation of America Holdings, and Veredus Laboratories
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post COVID-19 Rapid Diagnostic Test Market to See Booming Overall Study 2021-2028 | Abbott, F. Hoffmann-La Roche AG, Cardinal Health, Alfa Scientific Designs appeared first on Gatorledger.
